Gary Nowell
Internal Medicine · Madison, MSNPI 1114025905
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 215 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,410 and has fallen 72.1% since, to $393 in 2022.
Across 215 payments — averaging $14.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$571
- Boehringer Ingelheim$292
- Novo Nordisk$275
- Amgen$272
- Pfizer$184
- Amarin Pharma, Inc.$180
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,106100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $571 |
| Boehringer Ingelheim | 21 | $292 |
| Novo Nordisk | 21 | $275 |
| Amgen | 18 | $272 |
| Pfizer | 18 | $184 |
| Amarin Pharma, Inc. | 10 | $180 |
| Novartis | 11 | $171 |
| AstraZeneca | 9 | $162 |
| Merck | 9 | $147 |
| Johnson & Johnson | 9 | $126 |
| Astellas Pharma US Inc | 6 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| GSK | 4 | $58 |
| Abbott | 3 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Lilly USA, LLC | 4 | $50 |
| Sanofi-aventis U.S. LLC | 3 | $49 |
| Bayer | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Dexcom, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$3,106 in reported general payments places this provider in the 80th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Madison
- James BridgesMadison$23K
- Richard RussellMadison$11K
- Michael MorganMadison$10K
- J HarrisonMadison$9K
- Eric EvansMadison$8K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
- Brendan RossJackson$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.